MOLECULAR AND BIOLOGICAL CHANGES IN THE MYOCARDIUM OF MALE BALB/C MICE AT DIFFERENT STAGES OF AUTOIMMUNE MYOCARDITIS
https://doi.org/10.20340/mv-mn.2025.33(4).981
Abstract
Objective: to evaluate morphological and molecular biological changes in the myocardium of male BALB/c mice on days 14, 28, 42, and 60 of experimental autoimmune myocarditis.
Materials and Methods. Experimental autoimmune myocarditis was induced in adult male BALB/c mice (n=60) by three subcutaneous immunizations with porcine myocardial homogenate in complete Freund's adjuvant. Animals were sacrificed on days 14, 28, 42, and 60. Morphological examination was performed using hematoxylin and eosin staining, Mallory's trichrome staining, immunohistochemical analysis (CD3, CD68), and real-time quantitative PCR to assess the expression of Hif1a, Nfkb, Il1b, Il6, Il10, and Tgfb genes.
Results. On day 14, signs of acute inflammation were detected: lymphohistiocytic infiltration with CD3+ T lymphocytes and increased expression of Hif1a, Nfkb, Il1b, and Tgfb. By day 28, a decrease in pro-inflammatory gene expression and formation of fibrosis foci were observed. On day 42, expression levels of Il6, Il10, Hif1a, and Tgfb increased; morphologically, signs of cardiomyocyte damage were identified. By day 60, high expression of Il6 and Il10 persisted in the presence of myocytolysis.
Conclusion. The identified dynamics of molecular biological changes indicate the formation of a chronic inflammatory process with a predominance of anti-inflammatory cytokines IL-6 and IL-10 at late stages of autoimmune myocarditis in male BALB/c mice, which may contribute to disease progression and development of dilated cardiomyopathy.
About the Authors
Ekaterina А. Mel'nikovaRussian Federation
Postgraduate student, laboratory researcher at the Laboratory of Neuro-Morphology
Competing Interests:
The authors declare that they have no conflicts of interest in the planning, implementation, financing and use of the results of this study
Alexandra V. Sentyabreva
Russian Federation
Researcher at the Neuromorphology Laboratory
Competing Interests:
The authors declare that they have no conflicts of interest in the planning, implementation, financing and use of the results of this study
Ivan S. Cvetkov
Russian Federation
Candidate of Biological Sciences, Senior Researcher at the Laboratory of Immunomorphology of Inflammation
Competing Interests:
The authors declare that they have no conflicts of interest in the planning, implementation, financing and use of the results of this study
Anna M. Kosyreva
Russian Federation
Doctor of Biological Sciences, Leading Researcher, Head of the Neuromorphology Laboratory
Competing Interests:
The authors declare that they have no conflicts of interest in the planning, implementation, financing and use of the results of this study
References
1. Ammirati E, Moslehi JJ. Diagnosis and Treatment of Acute Myocarditis: A Review. Jama. 2023;329(13):1098–1113. https://doi.org/10.1001/jama.2023.3371
2. Khush KK, Cherikh WS, Chambers DS et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1056–66. https://doi.org/10.1016/j.healun.2019.08.004
3. Ponzoni M, Coles JG, Maynes JT. Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery. Int J Mol Sci. 2023;24(4). https://doi.org/10.3390/ijms24043162
4. Vicenzetto C, Giordani AS, Menghi C et al. The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review. Biomedicines. 2024;12(6). https://doi.org/10.3390/biomedicines12061156
5. Hua X, Hu G, Hu Q et al. Single-Cell RNA Sequencing to Dissect the Immunological Network of Autoimmune Myocarditis. Circulation. 2020;142(4):384–400. https://doi.org/10.1161/circulationaha.119.043545
6. Melnikova EA, Sentyabreva AV, Tsvetkov IS, Kosyreva AM. Biomolecular changes in the myocardium of female and male BALB/c mice with autoimmune myocarditis. Bulletin of Experimental Biology and Medicine. 2025;180(10):520–528. https://doi.org/10.47056/0365-9615-2025-180-10-520-528
7. Tada Y, Ogawa M, Watanabe R et al. Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditis. Expert Opin Investig Drugs. 2014;23(2):149–62. https://doi.org/10.1517/13543784.2014.855196
8. Dzhalilova DS, Makarova OV. The Role of Hypoxia-Inducible Factor in the Mechanisms of Aging. Biochemistry (Mosc). 2022;87(9):995–1014. https://doi.org/10.1134/s0006297922090115
9. Tkacz K, Rolski F, Stefańska M et al. TGF-β Signalling Regulates Cytokine Production in Inflammatory Cardiac Macrophages during Experimental Autoimmune Myocarditis. Int J Mol Sci. 2024;25(11). https://doi.org/10.3390/ijms25115579
10. White J, Jiang Z, Diamond M, Saed G. Hypoxia induces transforming growth factor beta 1 (TGFβ1) in human macrophages through a hypoxia inducible factor 1α; (HIF-1α) - dependent mechanism. Fertility and Sterility. 2009;92(3):S124. https://doi.org/10.1016/j.fertnstert.2009.07.1150
11. Rozen-Zvi B, Hayashida T, Hubchak SC et al. TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression. Am J Physiol Renal Physiol. 2013;305(4):F485–94. https://doi.org/10.1152/ajprenal.00215.2013
12. Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014;76:39–56. https://doi.org/10.1146/annurev-physiol-021113-170322
13. Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation. 2013;128(17):1910–23. https://doi.org/10.1161/circulationaha.113.003199
14. Hanawa H, Abe S, Hayashi M et al. Time course of gene expression in rat experimental autoimmune myocarditis. Clin Sci (Lond). 2002;103(6):623–32. doi: 10.1042/cs1030623
15. 15 Strizova Z, Benesova I, Bartolini R et al. M1/M2 macrophages and. their overlaps - myth or reality? Clin Sci (Lond). 2023;137(15):1067–93. https://doi.org/10.1042/cs20220531
16. Kothari P, Pestana R, Mesraoua R et al. IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages. J Immunol. 2014;192(1):349–57. https://doi.org/10.4049/jimmunol.1301906
17. Camporeale A, Marino F, Papageorgiou A et al. STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy. EMBO Mol Med. 2013;5(4):572–90. https://doi.org/10.1002/emmm.201201876
18. Tang YY, Wang DC, Wang YQ et al. Emerging role of hypoxia-inducible factor-1α in inflammatory autoimmune diseases: A comprehensive review. Front Immunol. 2022;13:1073971. https://doi.org/10.3389/fimmu.2022.1073971
19. 19 .Szabo-Fresnais N, Lefebvre F, Germain A et al. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. Cell Signal. 2010. 2010;22(7):1143–52. https://doi.org/10.1016/j.cellsig.2010.03.009
20. Fontes JA, Rose NR, Čiháková D. The varying faces of IL-6: From cardiac protection to cardiac failure. Cytokine. 2015;74(1):62–8. https://doi.org/10.1016/j.cyto.2014.12.024
Review
For citations:
Mel'nikova E.А., Sentyabreva A.V., Cvetkov I.S., Kosyreva A.M. MOLECULAR AND BIOLOGICAL CHANGES IN THE MYOCARDIUM OF MALE BALB/C MICE AT DIFFERENT STAGES OF AUTOIMMUNE MYOCARDITIS. Morphological newsletter. 2025;33(4):id-981. (In Russ.) https://doi.org/10.20340/mv-mn.2025.33(4).981
JATS XML




































